<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lichen Sclerosus | Clinical Quick-Scan</title>
    <style>
        :root {
            /* Color Palette */
            --bg-body: #f0f2f5;
            --bg-card: #ffffff;
            --text-main: #2d3436;
            --text-muted: #636e72;
            
            /* Semantic Colors */
            --color-primary: #0984e3; /* Blue - General Info */
            --color-primary-light: #e3f2fd;
            
            --color-danger: #d63031; /* Red - Flags/Emergency */
            --color-danger-bg: #ff7675;
            --color-danger-light: #fab1a0;
            
            --color-success: #00b894; /* Green - Treatment/Action */
            --color-success-bg: #55efc4;
            
            --color-warning: #fdcb6e; /* Yellow - Caution */
            
            /* Spacing & Radius */
            --radius: 12px;
            --shadow: 0 4px 6px rgba(0,0,0,0.05), 0 1px 3px rgba(0,0,0,0.1);
            --shadow-hover: 0 10px 15px rgba(0,0,0,0.1);
        }

        * { box-sizing: border-box; margin: 0; padding: 0; }
        
        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, Helvetica, Arial, sans-serif;
            background-color: var(--bg-body);
            color: var(--text-main);
            line-height: 1.5;
            padding: 20px;
        }

        /* --- Header --- */
        header {
            max-width: 1200px;
            margin: 0 auto 20px;
            display: flex;
            justify-content: space-between;
            align-items: center;
        }
        
        .header-title h1 {
            font-size: 1.8rem;
            color: var(--text-main);
            font-weight: 800;
        }
        
        .header-title p {
            color: var(--text-muted);
            font-size: 0.9rem;
        }

        .badge {
            background: var(--color-primary);
            color: white;
            padding: 4px 12px;
            border-radius: 20px;
            font-size: 0.8rem;
            font-weight: 600;
        }

        /* --- Grid Layout --- */
        .dashboard {
            display: grid;
            grid-template-columns: repeat(12, 1fr);
            gap: 20px;
            max-width: 1200px;
            margin: 0 auto;
        }

        /* --- Card Component --- */
        .card {
            background: var(--bg-card);
            border-radius: var(--radius);
            padding: 1.5rem;
            box-shadow: var(--shadow);
            transition: transform 0.2s ease, box-shadow 0.2s ease;
            border-left: 5px solid transparent;
            position: relative;
            overflow: hidden;
        }

        .card:hover {
            transform: translateY(-3px);
            box-shadow: var(--shadow-hover);
        }

        .card h2 {
            font-size: 1.1rem;
            margin-bottom: 1rem;
            display: flex;
            align-items: center;
            gap: 10px;
            text-transform: uppercase;
            letter-spacing: 0.5px;
        }

        .card h3 {
            font-size: 1rem;
            margin-top: 1rem;
            margin-bottom: 0.5rem;
            color: var(--text-main);
            border-bottom: 1px solid #eee;
            padding-bottom: 5px;
        }

        /* --- Card Variants --- */
        .card.summary {
            grid-column: span 12;
            border-left-color: var(--color-primary);
            background: linear-gradient(to right, #fff, var(--color-primary-light));
        }

        .card.red-flag {
            grid-column: span 6;
            border-left-color: var(--color-danger);
            background: linear-gradient(to right, #fff, #fff5f5);
        }
        
        .card.action-plan {
            grid-column: span 6;
            border-left-color: var(--color-success);
        }

        .card.symptoms {
            grid-column: span 12;
        }

        .card.management {
            grid-column: span 6;
        }

        .card.prognosis {
            grid-column: span 6;
        }

        /* --- Responsive --- */
        @media (max-width: 900px) {
            .card.red-flag, .card.action-plan, 
            .card.management, .card.prognosis {
                grid-column: span 12;
            }
        }

        /* --- Visual Elements --- */
        ul { list-style: none; }
        
        ul.bullet-list li {
            position: relative;
            padding-left: 20px;
            margin-bottom: 8px;
            font-size: 0.95rem;
        }
        
        ul.bullet-list li::before {
            content: "•";
            position: absolute;
            left: 0;
            color: var(--color-primary);
            font-weight: bold;
        }

        /* Red Flag List */
        .danger-list li {
            padding-left: 25px;
            margin-bottom: 12px;
            color: #b71c1c;
        }
        .danger-list li::before {
            content: "⚠";
            position: absolute;
            left: 0;
            font-size: 1.1em;
        }

        /* Action List */
        .action-list li {
            padding-left: 25px;
            margin-bottom: 10px;
            color: #00695c;
        }
        .action-list li::before {
            content: "✓";
            position: absolute;
            left: 0;
            font-weight: bold;
        }

        /* --- Tables --- */
        .comparison-table {
            width: 100%;
            border-collapse: collapse;
            font-size: 0.9rem;
        }
        
        .comparison-table th {
            text-align: left;
            padding: 10px;
            background: #f8f9fa;
            color: var(--text-muted);
        }
        
        .comparison-table td {
            padding: 10px;
            border-bottom: 1px solid #eee;
        }

        /* --- Treatment Regimen Box --- */
        .regimen-box {
            background: #e8f5e9;
            border: 1px solid var(--color-success);
            padding: 15px;
            border-radius: 8px;
            margin-top: 10px;
        }
        .regimen-step {
            display: flex;
            align-items: center;
            margin-bottom: 8px;
            font-weight: 500;
        }
        .step-tag {
            background: var(--color-success);
            color: white;
            width: 24px;
            height: 24px;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            margin-right: 10px;
            font-size: 0.8rem;
            flex-shrink: 0;
        }

        /* --- Tags --- */
        .tag {
            display: inline-block;
            padding: 2px 8px;
            border-radius: 4px;
            font-size: 0.75rem;
            font-weight: 700;
            margin-right: 5px;
        }
        .tag.female { background: #e3f2fd; color: #1565c0; }
        .tag.male { background: #f3e5f5; color: #7b1fa2; }

        /* --- Icons --- */
        .icon { width: 20px; height: 20px; fill: currentColor; }
        .icon-red { color: var(--color-danger); }
        .icon-green { color: var(--color-success); }
        .icon-blue { color: var(--color-primary); }

        /* --- Animations --- */
        @keyframes pulse-red {
            0% { border-left-color: var(--color-danger); }
            50% { border-left-color: var(--color-danger-light); }
            100% { border-left-color: var(--color-danger); }
        }
        .pulse-red {
            animation: pulse-red 2s infinite;
        }

        /* --- Footer --- */
        footer {
            max-width: 1200px;
            margin: 40px auto 0;
            text-align: center;
            font-size: 0.8rem;
            color: var(--text-muted);
            padding-top: 20px;
            border-top: 1px solid #ddd;
        }

        /* --- Toggle Switch for Treatment --- */
        .toggle-container {
            display: flex;
            margin-bottom: 15px;
            background: #eee;
            padding: 4px;
            border-radius: 8px;
        }
        .toggle-btn {
            flex: 1;
            padding: 8px;
            text-align: center;
            cursor: pointer;
            border-radius: 6px;
            font-weight: 600;
            transition: all 0.2s;
        }
        .toggle-btn.active {
            background: white;
            box-shadow: 0 2px 4px rgba(0,0,0,0.1);
            color: var(--color-primary);
        }
        .treatment-content { display: none; }
        .treatment-content.active { display: block; }

    </style>
</head>
<body>

    <header>
        <div class="header-title">
            <h1>Lichen Sclerosus</h1>
            <p>Quick-Scan Clinical Reference Tool</p>
        </div>
        <div class="badge">PRO REFERENCE</div>
    </header>

    <main class="dashboard">

        <!-- 1. SUMMARY CARD -->
        <article class="card summary">
            <h2>
                <svg class="icon icon-blue" viewBox="0 0 24 24"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-6h2v6zm0-8h-2V7h2v2z"/></svg>
                Overview
            </h2>
            <div style="display: flex; gap: 20px; flex-wrap: wrap;">
                <div style="flex: 1;">
                    <p><strong>Definition:</strong> Chronic inflammatory dermatosis affecting anogenital skin (women) / glans & prepuce (men). Old terms: BXO (men), kraurosis vulvae.</p>
                    <p style="margin-top: 10px;"><strong>Aetiology:</strong> Likely autoimmune in genetically predisposed patients. Association with thyroid disease (women) and smoking/diabetes (men).</p>
                </div>
                <div style="flex: 1; background: rgba(255,255,255,0.6); padding: 10px; border-radius: 8px;">
                    <strong>Epidemiology:</strong>
                    <ul class="bullet-list">
                        <li><strong>Women:</strong> ~3% prevalence (Peaks: Prepubertal & Postmenopausal).</li>
                        <li><strong>Men:</strong> ~0.07% prevalence (Peaks: Young boys & Adults).</li>
                        <li><strong>Boys with phimosis:</strong> 12-100% incidence.</li>
                    </ul>
                </div>
            </div>
        </article>

        <!-- 2. RED FLAGS (CRITICAL) -->
        <article class="card red-flag pulse-red">
            <h2>
                <svg class="icon icon-red" viewBox="0 0 24 24"><path d="M1 21h22L12 2 1 21zm12-3h-2v-2h2v2zm0-4h-2v-4h2v4z"/></svg>
                Red Flags & Actions
            </h2>
            <ul class="danger-list">
                <li><strong>Malignancy Risk (SCC):</strong> Lifetime risk of 4-5% for both sexes. Biopsy any persistent lump, thickening, or non-healing ulcer.</li>
                <li><strong>Biopsy Indications:</strong> Essential if lesions do not respond to treatment, presentation is atypical (young adults, pigmented, extragenital), or if malignancy is suspected.</li>
                <li><strong>Child Protection:</strong> Signs in girls can mimic sexual abuse (ecchymosis). Diagnosis of LS does NOT exclude abuse. Trauma can be a trigger.</li>
            </ul>
        </article>

        <!-- 3. DIFFERENTIAL DIAGNOSIS -->
        <article class="card action-plan">
            <h2>
                <svg class="icon icon-blue" viewBox="0 0 24 24"><path d="M15 4a8 8 0 100 16 8 8 0 000-16zM3 12a9 9 0 1118 0 9 9 0 01-18 0zm6 0a1 1 0 112 0 1 1 0 01-2 0zm4 0a1 1 0 112 0 1 1 0 01-2 0z"/></svg>
                Differential Diagnosis
            </h2>
            <div style="display: flex; flex-wrap: wrap; gap: 8px;">
                <span class="tag" style="background:#eee; color:#333;">Vitiligo</span>
                <span class="tag" style="background:#eee; color:#333;">Candida infection</span>
                <span class="tag" style="background:#eee; color:#333;">Lichen Planus</span>
                <span class="tag" style="background:#eee; color:#333;">Morphoea</span>
                <span class="tag" style="background:#eee; color:#333;">VIN / Bowen's Disease</span>
                <span class="tag" style="background:#eee; color:#333;">Graft-versus-host disease</span>
            </div>
            <p style="margin-top: 15px; font-size: 0.9rem; color: var(--text-muted);">
                <strong>Note:</strong> LS spares the vagina and cervix (unlike other conditions). Perianal involvement is common in women (~30%) but rare in men.
            </p>
        </article>

        <!-- 4. SYMPTOMS (COMPARISON) -->
        <article class="card symptoms">
            <h2>
                <svg class="icon icon-blue" viewBox="0 0 24 24"><path d="M12 4.5C7 4.5 2.73 7.61 1 12c1.73 4.39 6 7.5 11 7.5s9.27-3.11 11-7.5c-1.73-4.39-6-7.5-11-7.5zM12 17c-2.76 0-5-2.24-5-5s2.24-5 5-5 5 2.24 5 5-2.24 5-5 5zm0-8c-1.66 0-3 1.34-3 3s1.34 3 3 3 3-1.34 3-3-1.34-3-3-3z"/></svg>
                Clinical Presentation
            </h2>
            <table class="comparison-table">
                <thead>
                    <tr>
                        <th width="20%">Feature</th>
                        <th width="40%">Female</th>
                        <th width="40%">Male</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Key Symptom</strong></td>
                        <td>Itch (worse at night), Pain/Dyspareunia</td>
                        <td>Soreness, Phimosis, Poor urinary stream</td>
                    </tr>
                    <tr>
                        <td><strong>Signs</strong></td>
                        <td>White "figure-of-eight" patches (vulva/anus). Ecchymosis. Labial shrinking/fusing.</td>
                        <td>White patches on glans/prepuce. Meatal scarring/narrowing. Ballooning on urination.</td>
                    </tr>
                    <tr>
                        <td><strong>Complications</strong></td>
                        <td>Scarring (introitus narrowing), Clitoral pseudocyst, Constipation (fissures).</td>
                        <td>Phimosis, Urethral stricture (20%), Urinary retention.</td>
                    </tr>
                </tbody>
            </table>
        </article>

        <!-- 5. MANAGEMENT -->
        <article class="card management">
            <h2>
                <svg class="icon icon-green" viewBox="0 0 24 24"><path d="M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zm-9 14l-5-5 1.41-1.41L10 14.17l7.59-7.59L19 8l-9 9z"/></svg>
                Management Plan
            </h2>
            
            <!-- Toggle for Male/Female Treatment -->
            <div class="toggle-container">
                <div class="toggle-btn active" onclick="switchTab('female')">Female Protocol</div>
                <div class="toggle-btn" onclick="switchTab('male')">Male Protocol</div>
            </div>

            <!-- Female Content -->
            <div id="female-tx" class="treatment-content active">
                <div class="regimen-box">
                    <strong>First Line: Clobetasol Propionate 0.05%</strong>
                    <p style="font-size:0.85rem; margin-bottom:10px;">(Use ointment base. 30g tube should last 12 weeks)</p>
                    
                    <div class="regimen-step"><span class="step-tag">1</span> Month 1: Apply once daily (at night)</div>
                    <div class="regimen-step"><span class="step-tag">2</span> Month 2: Apply on alternate nights</div>
                    <div class="regimen-step"><span class="step-tag">3</span> Month 3: Apply twice weekly</div>
                    <div class="regimen-step"><span class="step-tag">4</span> Maintenance: As-required use</div>
                </div>
                <ul class="action-list" style="margin-top: 10px;">
                    <li>Review at 3 months.</li>
                    <li>If symptoms return, step back up to effective frequency.</li>
                    <li><strong>AVOID:</strong> Oestrogen or Testosterone creams (ineffective/unsafe).</li>
                </ul>
            </div>

            <!-- Male Content -->
            <div id="male-tx" class="treatment-content">
                <div class="regimen-box" style="background: #f3e5f5; border-color: #9c27b0;">
                    <strong>First Line: Ultra-potent topical steroids</strong>
                    <p style="font-size:0.85rem; margin-bottom:10px;">(Clobetasol propionate 0.05% applied once daily)</p>
                    
                    <div class="regimen-step"><span class="step-tag">1</span> Apply daily until remission achieved</div>
                    <div class="regimen-step"><span class="step-tag">2</span> Gradually reduce / intermittent use (e.g. weekly)</div>
                </div>
                <ul class="action-list" style="margin-top: 10px;">
                    <li><strong>Circumcision:</strong> Recommended if phimosis exists and NO response to steroids after 1-3 months.</li>
                    <li>Treat secondary infection if present.</li>
                    <li>Urethral strictures may require graft repair.</li>
                </ul>
            </div>
            
            <div style="margin-top: 15px; padding: 10px; background: #e1f5fe; border-radius: 6px;">
                <strong>General Advice:</strong>
                <ul class="bullet-list" style="margin-top: 5px;">
                    <li>Wash with bland emollients (e.g., aqueous cream).</li>
                    <li>Avoid irritants and tight clothing.</li>
                    <li>Use lubricants if necessary.</li>
                </ul>
            </div>
        </article>

        <!-- 6. PROGNOSIS -->
        <article class="card prognosis">
            <h2>
                <svg class="icon icon-blue" viewBox="0 0 24 24"><path d="M9 11.75c-.69 0-1.25.56-1.25 1.25s.56 1.25 1.25 1.25 1.25-.56 1.25-1.25-.56-1.25-1.25-1.25zm6 0c-.69 0-1.25.56-1.25 1.25s.56 1.25 1.25 1.25 1.25-.56 1.25-1.25-.56-1.25-1.25-1.25zM12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8 0-.29.02-.58.05-.86 2.36-1.05 4.23-2.98 5.21-5.37C11.07 8.33 14.05 10 17.42 10c.78 0 1.53-.09 2.25-.26.21.71.33 1.47.33 2.26 0 4.41-3.59 8-8 8z"/></svg>
                Prognosis & Follow-up
            </h2>
            <ul class="bullet-list">
                <li><strong>Women:</strong> Chronic condition. Symptom remission achievable (98% compliant), but maintenance often needed.</li>
                <li><strong>Men:</strong> Higher chance of cure. 50-60% cured by steroids, >75% cured by circumcision.</li>
                <li><strong>Girls:</strong> 75% prepubertal cases continue to need treatment after menarche.</li>
                <li><strong>Long-term:</strong> Annual review in primary care for stable patients.</li>
            </ul>
        </article>

    </main>

    <footer>
        <p>Reference: Patient.info Professional Review (Last updated June 2024).</p>
        <p style="margin-top:5px;">Disclaimer: This tool is for clinical reference only. Always use professional judgment.</p>
    </footer>

    <script>
        function switchTab(gender) {
            // Remove active class from buttons
            const buttons = document.querySelectorAll('.toggle-btn');
            buttons.forEach(btn => btn.classList.remove('active'));
            
            // Add active class to clicked button
            event.target.classList.add('active');

            // Hide all content
            document.getElementById('female-tx').classList.remove('active');
            document.getElementById('male-tx').classList.remove('active');

            // Show selected content
            if(gender === 'female') {
                document.getElementById('female-tx').classList.add('active');
            } else {
                document.getElementById('male-tx').classList.add('active');
            }
        }
    </script>
</body>
</html>